ArticleEinstein (Sao Paulo, Brazil)2026
Serum hepcidin measurement is related to clinical parameters and interferon-gamma in anemia of inflammation.
Article in Einstein (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to assess the relationship between hepcidin, IFN-γ, iron biomarkers, and clinical variables in patients with anemia of inflammation.
methodsA cross-sectional study was conducted. Ninety patients with inflammatory anemia and 70 healthy controls were evaluated. Laboratory parameters, serum hepcidin, and IFN-γ were determined using ELISA.
resultsThe mean age of patients with anemia of inflammation was 74.1±7.8 years, and most were female. Most patients reported ≥3 comorbidities (70%). Patients with ≥3 comorbidities had significantly higher levels of hepcidin (p<0.001). Hemoglobin, transferrin saturation index, and serum iron levels were significantly lower in patients with anemia of inflammation than in the control group (p<0.001). The erythrocyte sedimentation rate and ferritin and hepcidin levels increased in the anemia group (p<0.05). A significant positive correlation was observed between hepcidin and ferritin (r=0.372; p=0.001) and IFN-γ (r=0.228; p=0.004). Conversely, a significant negative correlation was found between hepcidin and hemoglobin (r=-0.355; p<0.001).
conclusionUnderstanding how inflammatory parameters and upregulated hepcidin levels act as biomarkers to assess iron homeostasis in anemia of inflammation may be effective for differential diagnosis and therapeutic approaches, such as iron supplementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.